Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Anorexia × Thalidomide × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Multiple Myeloma 103 Neoplasms, Plasma Cell 31 Neoplasms 12 Brain Neoplasms 12 Recurrence 11 Central Nervous System Neoplasms 11 Glioblastoma 10 Carcinoma, Hepatocellular 10 Melanoma 9 Prostatic Neoplasms 8 Leukemia 8 Gliosarcoma 8 Carcinoma, Non-Small-Cell Lung 8 Carcinoma, Renal Cell 7 Waldenstrom Macroglobulinemia 6 Lung Neoplasms 6 Glioma 6 Sarcoma 5 Lymphoma, B-Cell, Marginal Zone 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Kidney Neoplasms 5 Immunoglobulin Light-chain Amyloidosis 5 Colorectal Neoplasms 5 Myelodysplastic Syndromes 4 Lymphoma 4 Colonic Neoplasms 4 Astrocytoma 4 Rectal Neoplasms 3 Oligodendroglioma 3 Neuroblastoma 3

Interventions

Megestrol Acetate 7 Olanzapine 3 Mirtazapine 3 anamorelin 2 Infliximab 2 nabiximols 1 nabilone 1 Watchful Waiting 1 Thalidomide 1 Surveys and Questionnaires 1 Sugars 1 Radiotherapy 1 Quality of Life 1 Palonosetron 1 Observation 1 Nicotine 1 Modafinil 1 Minocycline 1 Melatonin 1 Megestrol 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Flurandrenolone 1 Etanercept 1 EOM613 1 Docetaxel 1 Dexamethasone 1 Creatine 1 Calcium Dobesilate 1 Aromatherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00379353 2013-02-04

The Effects of Thalidomide on Symptom Clusters

M.D. Anderson Cancer Center

Phase 2 Completed

32 enrolled 14 charts

Anorexia, Fatigue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡